FDA chief: COVID, mail mix-up delayed action on baby formula
WASHINGTON (AP) — The head of the Food and Drug Administration said Wednesday that efforts to investigate problems at a baby formula plant linked to the nationwide shortage were slowed by COVID-19, scheduling conflicts and even a missing piece of mail.
FDA Commissioner Robert Califf laid out a series of setbacks in congressional testimony that slowed his agency's response by months, including a whistleblower complaint that didn't reach FDA leadership due to a "mailroom failure...
Support Local News
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
Daily Inter Lake - everything
Print delivery, e-edition and unlimited website access
- $26.24 per month
Daily Inter Lake - unlimited website access
- $9.95 per month